Ignite Creation Date:
2024-05-06 @ 8:18 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06337305
Status:
COMPLETED
Last Update Posted:
2024-03-29
First Post:
2024-03-08
Brief Title:
Resiliency in Patients Undergoing Radical Cystectomy for Bladder Cancer
Sponsor:
University of Kansas Medical Center
Organization:
University of Kansas Medical Center
Study Overview
Official Title:
Resiliency in Patients Undergoing Radical Cystectomy for Bladder Cancer
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective cross-sectional survey-based study composed of both a retrospective chart review and 3-series patient survey This study will help elicit potential areas throughout the perioperative course of radical cystectomy to improve patient resilience and quality of life providing opportunity for future interventional studies
Detailed Description:
This is a prospective cross-sectional survey-based study composed of both a retrospective chart review and 3-series patient survey This study will help elicit potential areas throughout the perioperative course of radical cystectomy to improve patient resilience and quality of life providing opportunity for future interventional studies Primarily the study will evaluate health related quality of life and resiliency in patients throughout the perioperative course of a radical cystectomy for bladder cancer
The primary objective will be the correlation of the Connor-Davidson Resilience Scale CD-RISC-25 and the Functional Assessment of Cancer Therapy-Bladder-Cystectomy FACT-BL-Cys score
Patients will be identified and undergo consent and baseline assessments including completion of surveys prior to their cystectomy A retrospective chart review will also be completed to record information regarding patients cancer stage treatment status diagnosis date insurance type and related medical conditions and medications Data from retrospective chart review will be collected and recorded in a secure REDCap database for all eligible patients
Subsequent surveys will be administered again at approximately 10-30 days postoperatively as well as 60-120 days postoperatively
The primary objective will be the correlation of the Connor-Davidson Resilience Scale CD-RISC-25 and the Functional Assessment of Cancer Therapy-Bladder-Cystectomy FACT-BL-Cys score
Patients will be identified and undergo consent and baseline assessments including completion of surveys prior to their cystectomy A retrospective chart review will also be completed to record information regarding patients cancer stage treatment status diagnosis date insurance type and related medical conditions and medications Data from retrospective chart review will be collected and recorded in a secure REDCap database for all eligible patients
Subsequent surveys will be administered again at approximately 10-30 days postoperatively as well as 60-120 days postoperatively
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None